United States securities and exchange commission logo

                            March 14, 2023

       Nicholas Liveris
       Chief Financial Officer
       Novonix Limited
       Level 38
       71 Eagle Street
       Brisbane, QLD 4000 Australia

                                                        Re: Novonix Limited
                                                            Form 20-F for the
Transition Period July 1, 2022 to December 31, 2022
                                                            Filed February 28,
                                                            File No. 001-41208

       Dear Nicholas Liveris:

              We have limited our review of your filing to the financial
statements and related
       disclosures and have the following comments. In some of our comments, we
may ask you to
       provide us with information so we may better understand your disclosure.

              Please respond to these comments within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comments apply to your facts and circumstances, please tell us why in
your response.

                                                        After reviewing your
response to these comments, we may have additional comments.

       Form 10-F for the Transition Period July 1, 2022 to December 31, 2022

       Item 18. Financial Statements
       Notes to the consolidated financial statements
       Note 15 Financial Assets at Fair Value Through Profit or Loss, page F-38

   1.                                                   We note your policy
that the group subsequently measures all equity investments at fair
                                                        value and that you have
recorded a loss on equity investment securities at fair value
                                                        through profit and loss
for the twelve months ended June 30, 2022. It does not appear that
                                                        there has been a change
in fair value other than exchange difference during the six months
                                                        ended December 31,
2022. Please tell us how you concluded that there was no change in
                                                        fair value subsequent
to June 30, 2022. Refer to paragraph 5.7.1 of IFRS 9.
 Nicholas Liveris
Novonix Limited
March 14, 2023
Page 2

       In closing, we remind you that the company and its management are
responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review,
comments, action or
absence of action by the staff.

      You may contact Melissa Gilmore at (202) 551-3777 or Kevin Woody at (202)
3629 with any questions.

FirstName LastNameNicholas Liveris                        Sincerely,
Comapany NameNovonix Limited
                                                          Division of
Corporation Finance
March 14, 2023 Page 2                                     Office of
FirstName LastName